Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer-Reference-Cited by-同舟云学术

Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer

Published:2020-12 Issue: Volume:19 Page:57-66
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Béguin Jérémy,Foloppe Johann,Maurey Christelle,Laloy Eve,Hortelano Julie,Nourtier Virginie,Pichon Christelle,Cochin Sandrine,Cordier Pascale,Huet Hélène,Quemeneur Eric,Klonjkowski Bernard,Erbs Philippe

Funder

Industrial Training Convention for Research

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference57 articles.

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma;Andtbacka;J. Clin. Oncol.,2015

2. New viruses for cancer therapy: meeting clinical needs;Miest;Nat. Rev. Microbiol.,2014

3. Trial Watch-Oncolytic viruses and cancer therapy;Pol;OncoImmunology,2015

4. Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery;Haddad;Front. Oncol.,2017

5. Poxvirus tropism;McFadden;Nat. Rev. Microbiol.,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding FCU1 gene to exert an efficient anti-tumoral activity;Frontiers in Oncology;2024-07-18

2. A viral attack on brain tumors: the potential of oncolytic virus therapy;Journal of NeuroVirology;2024-05-28

3. Oncolytic Viruses in Cancer Immunotherapy;Advanced Therapeutics;2024-05-22

4. Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma;International Journal of Molecular Sciences;2024-02-07

5. 3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding FCU1 gene to exert an efficient anti-tumoral activity;2023-12-06